Literature DB >> 3308210

Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.

U Sengupta1, S Sinha, G Ramu, J Lamb, J Ivanyi.   

Abstract

Delayed hypersensitivity skin reactions to tuberculin when injected alone or in mixture with antigens of M. leprae were examined in leprosy patients and in healthy controls. The tuberculin reaction was significantly inhibited in more than one half of both LL and BT patients by the soluble extract of M. leprae (leprosin), the leprosin derived 12 kD protein or leprosin depleted of the 12 kD antigen. However, suppression was not found in healthy controls from a leprosy endemic region. These results suggest that multiple M. leprae-specific antigens have an immunoregulatory function. Since suppression was demonstrable not only in LL (leprosin-anergic), but also in BT (leprosin-responder) patients it is of interest that the 'mixed' skin test can discriminate the immune status of at least certain BT patients from that of the infected but self-healing healthy controls. Corollary lymphocyte cultures failed to show any suppression by leprosing of the lymphoproliferative responses to tuberculin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308210      PMCID: PMC1542691     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Lepromin-induced suppressor cells in patients with leprosy.

Authors:  V Mehra; L H Mason; J P Fields; B R Bloom
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Preliminary evidence for the trapping of antigen-specific lymphocytes in the lymphoid tissue of 'anergic' tuberculosis patients.

Authors:  G A Rook; J W Carswell; J L Stanford
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

3.  Role of macrophages in defective cell mediated immunity in lepromatous leprosy. I. Factor(s) from macrophages affecting protein synthesis and lymphocyte transformation.

Authors:  P R Salgame; T J Birdi; P R Mahadevan; N H Antia
Journal:  Int J Lepr Other Mycobact Dis       Date:  1980-06

4.  In vitro induction of human suppressor T cells by mycobacterial antigens. BCG activated OKT4+ cells mediate suppression of antigen induced T cell proliferation.

Authors:  A S Mustafa; T Godal
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

5.  T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy.

Authors:  A Haregewoin; T Godal; A S Mustafa; A Belehu; T Yemaneberhan
Journal:  Nature       Date:  1983-05-26       Impact factor: 49.962

6.  Studies on the defect in cell-mediated immunity in lepromatous leprosy using HLA-D-identical siblings. Absence of circulating suppressor cells and evidence that the defect is in the T-lymphocyte, rather than the monocyte, population.

Authors:  G L Stoner; R N Mshana; J Touw; A Belehu
Journal:  Scand J Immunol       Date:  1982-01       Impact factor: 3.487

7.  In vitro stimulation of lymphocytes in leprosy patients, healthy contacts of leprosy patients, and subjects not exposed to leprosy. Comparison of an antigen fraction prepared from Mycobacterium leprae and tuberculin-purified protein derivative.

Authors:  O Closs; L J Reitan; K Negassi; M Harboe; A Belehu
Journal:  Scand J Immunol       Date:  1982-08       Impact factor: 3.487

8.  Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals.

Authors:  A H Smelt; R J Rees; F Y Liew
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

9.  Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy.

Authors:  W E Bullock; S Watson; K E Nelson; V Schauf; S Makonkawkeyoon; R R Jacobson
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

10.  Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.

Authors:  I Nath; J J Van Rood; N K Mehra; M C Vaidya
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

View more
  6 in total

Review 1.  Immunological study of the defined constituents of mycobacteria.

Authors:  J Ivanyi; K Sharp; P Jackett; G Bothamley
Journal:  Springer Semin Immunopathol       Date:  1988

2.  Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.

Authors:  P E Fine; P J Gruer; N Maine; J M Ponnighaus; R J Rees; J L Stanford
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

3.  Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.

Authors:  G Kaplan; E P Sampaio; G P Walsh; R A Burkhardt; T T Fajardo; L S Guido; A de Miranda Machado; R V Cellona; R M Abalos; E N Sarno
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy.

Authors:  V T Trao; P L Huong; A T Thuan; D D Anh; D D Trach; G A Rook; E P Wright
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

5.  T-cell recognition of mycobacterial GroES peptides in Thai leprosy patients and contacts.

Authors:  B Chua-Intra; S Peerapakorn; N Davey; S Jurcevic; M Busson; H M Vordermeier; C Pirayavaraporn; J Ivanyi
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

6.  Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study.

Authors:  Becky L Rivoire; Nathan A Groathouse; Stephen TerLouw; Kapil Dev Neupane; Chaman Ranjit; Bishwa Raj Sapkota; Saraswoti Khadge; Chhatra B Kunwar; Chatra B Kunwar; Murdo Macdonald; Rachel Hawksworth; Min B Thapa; Deanna A Hagge; Melinda Tibbals; Carol Smith; Tina Dube; Dewei She; Mark Wolff; Eric Zhou; Mamodikoe Makhene; Robin Mason; Christine Sizemore; Patrick J Brennan
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.